|
Post by qwertqwert on Oct 12, 2017 10:53:35 GMT -5
|
|
|
Post by kc on Oct 12, 2017 11:01:16 GMT -5
still going? I just tuned in but its a commercial
|
|
|
Post by compound26 on Oct 12, 2017 11:02:31 GMT -5
still going? I just tuned in but its a commercial Just ended a minute ago.
|
|
|
Post by kc on Oct 12, 2017 11:04:53 GMT -5
Darn
|
|
N
Newbie
Posts: 1
|
Post by N on Oct 12, 2017 11:09:16 GMT -5
If you follow the link posted by qwertqwert and go to channel 111 you can listen to what is live now. At the top of the screen you actually can click the skip backward button to the prior segments and you can listen to the interview there. That is what I was able to do. The segment is called "Knowledge@Wharton LIVE - Inhalable Insulin"
|
|
|
Post by qwertqwert on Oct 12, 2017 11:09:16 GMT -5
still going? I just tuned in but its a commercial Just ended a minute ago. should be rebroadcast in the on demand section soon enough... one thing I caught - he mentioned China request for approval in aprx 1-2 weeks when referring to latest news on China.
|
|
|
Post by humann on Oct 12, 2017 11:19:24 GMT -5
could certainly be one explanation for why some investors wanted to lock in shares @$6/sh if there is going to be progress in the Chinese market.
|
|
|
Post by qwertqwert on Oct 12, 2017 11:30:26 GMT -5
should be rebroadcast in the on demand section soon enough... one thing I caught - he mentioned China request for approval in aprx 1-2 weeks when referring to latest news on China. Sorry, it was Brazil not china..
|
|
|
Post by peppy on Oct 12, 2017 11:35:36 GMT -5
oh, ha ha. ok, brazil mentioned. (Insulin human [rDNA])
|
|
|
Post by patten1962 on Oct 12, 2017 11:50:38 GMT -5
Stock price is taking off. What the he ll did he say???
|
|
|
Post by therealisaching on Oct 12, 2017 11:52:16 GMT -5
It was a really good 1/2 hour conversational segment. Not quite detailed like an investor call, but definately business oriented.
To listen you can use that link & click 111 in the search button. It brings up the channel live.
Once there scroll down & look for the show "Knowledge @ Wharton". It will bring up the entire replay. Mike starts around noon in the last segment.
Some hightlights:
He talked about the company has surpassed the results of the former partner using 1/7th of the resources. $30MM vs $200MM.
Confirmed the capital raise yesterday.
They talked about cgm's & using Iphones. Per Mike now that you can see what your blood sugar is doing every 5 minutes. This is different feedback than you've ever had in your life. Hey, theres my sugar, let me fix it.
He was asked how do you respond to the naysayers, that this is a failed company. His response was talk to our consituents. You can see our patients all over social media, twitter, facebook, youtube. He has never seen patient advocacy for a drug like this in his entire career. He added, this has been a new start done with again 1/7th of what their former partner used and done on a shoe string. Mentioned there has been concern about the financial position of the company and the capital raise will make a big differerence.
He had 1 major payor that have been negotiating with call him yesterday to congratulate on the label change and cap raise. Those discussions are ongoing.
He also mentioned they are on the cusp of announcing within a week or two Brazil news. I couldnt quite make that out. It sounded like filing.
Well worth your time.
The Castagna effect. While he was talking the price moved 11% from 5.25 to 5.85!
|
|
|
Post by sellhighdrinklow on Oct 12, 2017 11:52:28 GMT -5
Castagna said, " ....on cusp of announcing We did a partnership in Brazil and we will be announcing this filing in the next week or so..."
|
|
|
Post by qwertqwert on Oct 12, 2017 11:55:29 GMT -5
|
|
|
Post by patten1962 on Oct 12, 2017 11:58:49 GMT -5
|
|
|
Post by rockstarrick on Oct 12, 2017 12:00:48 GMT -5
|
|